Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 246 (RNA5SP246) is a noncoding RNA pseudogene that shares sequence homology with functional 5S ribosomal RNA genes but lacks coding potential due to mutations or deletions. Pseudogenes of the 5S rRNA family arise from duplication events and accumulate mutations that render them nonfunctional. Unlike functional 5S rRNA, which is an essential component of the ribosome and participates in protein synthesis, RNA5SP246 is not incorporated into ribosomes and does not play a role in ribosomal structure or function. Pseudogenes can sometimes exert regulatory effects at the RNA level, such as silent competition for regulatory factors, but there is no evidence to suggest any biological activity or therapeutic relevance for RNA5SP246 specifically. This entity is not considered a valid therapeutic target and is primarily annotated in genomic databases as a reference pseudogene.
none applicable (Since it is not a functional target, there is no mechanism of action for drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 246 (RNA5SP246).